T. Moon

发表

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

D. Alberts, A. Hamburger, S. Salmon, 1978, The New England journal of medicine.

Development and Use of a Natural History Data Base of Breast Cancer Studies

T. Powles, G. Bonadonna, Stephen E. Jones, 1987, American journal of clinical oncology.

Oritavancin, a New Lipoglycopeptide Antibiotic: Results From a Thorough QT Study

J. Mason, B. Darpo, T. Moon, 2010, Journal of clinical pharmacology.

Spaulding Blinding in Active-Controlled Cardiac Repolarization Studies Pharmacokinetics and Pharmacodynamics of Three Moxifloxacin Dosage Forms : Implications for

J. Mason, C. Garnett, J. Florian, 2010 .

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.

D. Alberts, Y. Peng, T. Moon, 1980, British Journal of Cancer.

Kinetics of intravenous melphalan

T. L. Evans, D. Alberts, J. Gross, 1979, Clinical pharmacology and therapeutics.

Effects of long-term intake of retinol on selected clinical and laboratory indexes.

B. Cartmel, N. Levine, T. Moon, 1999, The American journal of clinical nutrition.

Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

D. Alberts, B. Cartmel, Y. Peng, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Effects of long-term intake of retinol on selected clinical and laboratory indexes 1–3

B. Cartmel, N. Levine, T. Moon, 1999 .

Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children. A report of the intergroup rhabdomyosarcoma study (IRS)

W. Newton, T. Moon, M. Tefft, 1978, Cancer.

Design and analysis of the ESVEM Trial.

K. P. Anderson, T. Moon, E. Hahn, 1996, Progress in cardiovascular diseases.

Extraskeletal Ewing's sarcoma: a preliminary review of 26 cases encountered in the Intergroup Rhabdomyosarcoma Study.

W. Newton, M. Tefft, T. Moon, 1978, Cancer.

Vitamin A: evidence for its preventive role in human cancer.

F. Meyskens, T. Moon, T. Kummet, 1983, Nutrition and cancer.

Attitudes and practices of primary care physicians for prostate cancer screening.

M. Papenfuss, R. Hoffman, T. Moon, 1996, American journal of preventive medicine.

Dose response evaluation of adriamycin in human neoplasia

B. Hoogstraten, L. Baker, S. Salmon, 1977, Cancer.

Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.

D. Alberts, J. Davis, C. Johnson, 1994, Journal of the National Cancer Institute.

Nutrition and cancer prevention: investigating the role of micronutrients.

M. Micozzi, T. Moon, 1989 .

Comparison of bone scintigraphy and radiography in multiple myeloma.

J. Woolfenden, M. Pitt, B. Durie, 1980, Radiology.

Immunocompetence and malignant lymphoma: Immunologic status before therapy

S. Jones, T. Anderson, B. Soehnlen, 1981, Cancer.

Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).

H. Garewal, S. Jones, R. Heusinkveld, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

ASSISTANT DIRECTOR, CANCER CENTER DIRECTOR OF BIOMETRY, COMPUTING & EPIDEMIOLOGY

D. Alberts, Y. Peng, T. Moon, 1986 .

Clinical trials of cancer prevention agents: true versus observed prevention effect.

T. Moon, 1986, Statistics in medicine.

Human Tumor Stem-Cell Assay

I. Tannock, D. Alberts, M. Aapro, 1983 .

The ESVEM Trial: Electrophysiologic Study Versus Electrocardiographic Monitoring for Selection of Antiarrhythmic Therapy of Ventricular Tachyarrhythmias

Jeffrey L. Anderson, J. Bigger, J. Mason, 1989, Circulation.

Bleomycin pharmacokinetics in man. II. Intracavitary administration.

D. Alberts, D. Perrier, J. Gross, 1979, Cancer chemotherapy and pharmacology.

Bleomycin pharmacokinetics in man

D. Alberts, D. Perrier, J. Gross, 2004, Cancer Chemotherapy and Pharmacology.

Comparison of Different Trials of Adjuvant Chemotherapy in Stage II Breast Cancer Using a Natural History Data Base

T. Powles, G. Bonadonna, Stephen E. Jones, 1987, American journal of clinical oncology.

Prognosis in children with metastatic rhabdomyosarcoma.

J. Okamura, T. Moon, W. Sutow, 1977, Medical and pediatric oncology.

Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.

D. Alberts, M. Aapro, Stephen E. Jones, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1-year followup of cardiac status after adriamycin therapy.

G. Ewy, S. Jones, T. Moon, 1979, Cancer treatment reports.

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.

C. Coltman, B. Hoogstraten, R. Benjamin, 1976, Cancer treatment reports.

Histopathologic review of lymphoma cases from the southwest oncology group

C. Coltman, S. Jones, J. Butler, 1977, Cancer.

Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.

J. Dean, L. Einhorn, R. Dorr, 1979, The New England journal of medicine.

Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model.

D. Alberts, T. Cetas, J. Hoeschele, 1980, Journal of the National Cancer Institute.

Quantitation of the number of cells within tumor colonies in semisolid medium and their growth as oblate spheroids.

F. Meyskens, T. Moon, S. P. Thomson, 1984, Cancer research.

Oral melphalan kinetics

T. L. Evans, D. Alberts, S. Chang, 1979, Clinical pharmacology and therapeutics.

Lymphatic metastasis with childhood rhabdomyosarcoma

T. Moon, D. Hays, W. Lawrence, 1977, Cancer.

Cutaneous Malignant Melanoma 11. The Natural History and Prognostic Factors Influencing the Development of Stage I1 Disease

L. Loescher, T. Moon, B. Parks, 2006 .

Human tumor cloning: drug sensitivity testing clinical correlations.

D. Alberts, S. Salmon, T. Moon, 1982, Progress in clinical cancer.

Moxifloxacin Increases Heart Rate in Humans

J. Mason, T. Moon, 2017, Antibiotics.

Plasma kinetics of oral retinol in cancer patients.

D. Alberts, G. Goodman, Y. Peng, 1984, Cancer treatment reports.

The Myocarditis Treatment Trial: design, methods and patients enrollment.

B. McManus, J. Mason, A. Herskowitz, 1995, European heart journal.

Macronutrients: Investigating Their Role in Cancer

M. Micozzi, T. Moon, 1992 .

Chemotherapy of ovarian cancer directed by the human tumor stem cell assay

D. Alberts, S. Salmon, F. Meyskens, 2004, Cancer Chemotherapy and Pharmacology.

Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma.

S. Salmon, L. Loescher, T. Moon, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.

S. Salmon, F. Meyskens, B. Durie, 1982, Cancer research.

Rural Coalition Meeting

S. Salmon, F. Meyskens, T. Moon, 1994, Environmental Health Perspectives.

Quantitation of drug sensitivity by human metastatic melanoma colony-forming units.

S. Salmon, F. Meyskens, T. Moon, 1981, British Journal of Cancer.

Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.

C. Coltman, S. Jones, T. Moon, 1977, Cancer treatment reports.

Tumor growth stimulation in vitro by interferons.

S. Salmon, B. Durie, T. Moon, 1983, European journal of cancer & clinical oncology.

Malignant melanoma in southern Arizona. Increasing incidence and sunlight as an etiologic factor.

P. Bozzo, T. Moon, M. Schreiber, 1981, Archives of dermatology.

Predictors for cutaneous basal‐ and squamous‐cell carcinoma among actinically damaged adults

D J Roe, D. Alberts, A. Giuliano, 2001, International journal of cancer.

Estrogens and disease prevention.

T. Moon, 1991, Archives of internal medicine.

retroviral construct administered by peripheral intravenous infusion Phase 1 trial of FVIII gene transfer for severe hemophilia A using a

H. Roehl, M. Ragni, G. White, 2013 .

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.

H. Roehl, M. Ragni, G. White, 2003, Blood.

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

Q. Dong, C. Balch, A. Buzaid, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Electrocardiographic reference ranges derived from 79,743 ambulatory subjects.

Jay W Mason, J. Mason, Douglas J Ramseth, 2007, Journal of electrocardiology.

Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy

D. Alberts, S. Salmon, F. Meyskens, 2004, Cancer Chemotherapy and Pharmacology.

Clinical correlations of in vitro drug sensitivity.

D. Alberts, S. Salmon, S. Jones, 1980, Progress in clinical and biological research.

The risk of developing subsequent nonmelanoma skin cancers.

S. H. Fox, T. Moon, J. Davidson, 1990, Journal of the American Academy of Dermatology.

Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.

K. Griffith, Robin B Harris, R. B. Harris, 2001, Journal of the American Academy of Dermatology.

Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group.

D. Alberts, C. Ritenbaugh, B. Cartmel, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Clinical correlations of drug sensitivity in the human tumor stem cell assay.

D. Alberts, S. Salmon, S. Jones, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma

V. Vaitkevicius, G. Bodey, T. Moon, 1977, Cancer.

Retinoids in prevention of skin cancer.

B. Cartmel, N. Levine, T. Moon, 1997, Cancer letters.

Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease

F. Meyskens, L. Loescher, T. Moon, 1989, Cancer.

Familial clustering of hepatitis B surface antigen among Panamanian Indians.

R. Purcell, W. Reeves, C. Peters, 1975, The Journal of infectious diseases.

Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma.

S. Salmon, Salmon Se, B. Durie, 1980, Blood.

Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, 5‐fluorouracil, and prednisone in solid tumors

C. Coltman, S. Balcerzak, J. Saiki, 1977, Cancer.

Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma

E. Hersh, T. Moon, J. Hewlett, 1977, Cancer.

Superiority of adriamycin‐containing combination chemotherapy in the treatment of diffuse lymphoma. A southwest oncology group study

C. Coltman, F. Morrison, S. Jones, 1979, Cancer.

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

C. Coltman, H. Wilson, S. Jones, 1976, Cancer.

Combination intrathecal therapy for meningeal leukemia: two versus three drugs

G. Humphrey, T. Vietti, R. Trueworthy, 1977 .

Adriamycin therapy in previously treated adult acute leukemia.

J. Saiki, H. Wilson, F. Morrison, 1977, Cancer treatment reports.

Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma.

F. Cabanillas, J. Butler, V. Rodriguez, 1978, Archives of internal medicine.

Nabilone: a potent antiemetic cannabinol with minimal euphoria.

J. Dean, S. Salmon, R. Dorr, 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease

F. Meyskens, L. Loescher, T E Moon, 1988, Cancer.

IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemia.

R. Purcell, W. Dietz, C. Peters, 1976, Clinical and experimental immunology.

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

B. McManus, J. Mason, A. Herskowitz, 1995, The New England journal of medicine.

Influence of time and therapy on ventricular defibrillation in dogs

C W Otto, G A Ewy, C. Otto, 1980, Critical care medicine.

The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer

Stephen E. Jones, T. Moon, F. Ahmann, 1988, Journal of surgical oncology.

A fundamental relationship between intraventricular conduction and heart rate.

Fabio Badilini, Jay W Mason, Martino Vaglio, 2016, Journal of electrocardiology.

Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.

M. Gottardis, R. Heyman, W. Lamph, 1998, Cancer research.

Rhabdomyosarcoma: surgical therapy in extremeity lesions in children.

T. Moon, D. Hays, M. Tefft, 1977, The Orthopedic clinics of North America.

RHabdomyosarcoma: Response with chemotherapy prior to radiation in patients with gross residual disease

T. Moon, M. Tefft, Carlos H. Fernandez, 1977, Cancer.

Pharmacokinetics of bleomycin in man

S. E. Salmon, D. Alberts, J. Gross, 2004, Cancer Chemotherapy and Pharmacology.

Clinical-biologic patterns of metastatic melanoma and their effect on treatment.

F. Meyskens, T. Moon, D. Berdeaux, 1985, Cancer treatment reports.

Correlation between amounts of cellular membrane components and sensitivity to hyperthermia in a variety of mammalian cell lines in culture.

E. Gerner, A. Cress, T. Moon, 1982, Cancer Research.

Evaluation of an automated image analysis system for counting human tumor colonies.

S. Salmon, J. LeBowitz, T E Moon, 1984, International journal of cell cloning.

Combination intrathecal therapy for meningeal leukemia: two versus three drugs.

G. Humphrey, T. Vietti, R. Trueworthy, 1977, Blood.

Improved survival of patients with advanced breast cancer treated with adriamycin-cyclophosphamide plus tamoxifen (TAC)

Stephen E. Jones, T. Moon, F. Ahmann, 1981 .

Hypoplastic acute leukemia: Review of 70 cases with multivariate regression analysis

L. Glasser, T. Moon, B. Durie, 1986, Hematological oncology.

Using a database of protocol studies to evaluate therapy: a breast cancer example.

T. Powles, G. Bonadonna, S. Jones, 1984, Statistics in Medicine.

Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy

Steward L. Davis, S. Salmon, S. Jones, 1980, Cancer.

The risk of cancer and serum vitamin A and E and carotenoids.

D. Alberts, F. Meyskens, T. Moon, 1984, The New England journal of medicine.

Planning the analysis of a breast cancer prevention trial.

T. Moon, 1991, Preventive medicine.

The role of lymphangiography in vulvar carcinoma.

M. Kao, J. Lee, T. Moon, 1986, American journal of obstetrics and gynecology.

Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.

D. Alberts, S. Salmon, T. Moon, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study.

D. Alberts, R. O’Toole, H. Wilson, 1979, Cancer treatment reports.

Pharmacologic studies of anticancer drugs with the human tumor stem cell assay

D. Alberts, S. Salmon, T. Moon, 2004, Cancer Chemotherapy and Pharmacology.

A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation

J. Mason, A. Dietz, T. Moon, 2014, Cancer management and research.

Comparison of the effects of subcutaneous APF530, intravenous granisetron, moxifloxacin, and placebo on the QT interval in humans.

J. Mason, A. Dietz, T. Moon, 2013 .

Pharmacokinetics and Repolarization Effects of Intravenous and Transdermal Granisetron

J. Mason, J. Howell, T. Moon, 2012, Clinical Cancer Research.

Predictors of inactivation and reasons for participant inactivation during a skin cancer chemoprevention study.

D. Alberts, B. Cartmel, N. Levine, 2000, Cancer Epidemiology, Biomarkers and Prevention.

The new cancer prevention and control.

E. Gritz, T. Moon, 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial.

S. Salmon, S. Jones, R. Heusinkveld, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.

D. Alberts, T. Moon, S. Rivkin, 1979, Cancer treatment reports.

Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management

J. Mason, T. Moon, 2013, Cancer management and research.

Kinetics of clonogenic melanoma cell proliferation and the limits on growth within a bilayer agar system

T. Moon, S. P. Thomson, F. Meyskens, 1984, Journal of cellular physiology.

Comparison of two physical activity questionnaires, with a diary, for assessing physical activity in an elderly population.

B. Cartmel, T. Moon, 1992, Journal of clinical epidemiology.

Chronic solar ultraviolet damage associated with malignant melanoma of the skin.

P. Bozzo, T. Moon, M. Schreiber, 1984, Journal of the American Academy of Dermatology.

Treatment of early breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: initial results of a brief and effective adjuvant program.

S. Salmon, S. Jones, R. Miller, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.